Market Overview:
The global peptide and heparin market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in peptide and heparin therapies. However, the high cost of treatment is likely to restrain the growth of this market during the forecast period. Based on type, the global peptide and heparin market has been segmented into intravenous, oral route, and others. The intravenous segment is expected to account for a major share of the global peptide and heparin market in 2018 owing to its widespread use in hospitals for treating various medical conditions. By application, hospital pharmacies accounted for a major share of the global peptide and heparin market in 2017 owing to their large customer base across all regions.
Product Definition:
A peptide is a molecule composed of two or more amino acids linked by peptide bonds. Peptides are important molecules in the body, playing a role in many biochemical processes. For example, they are involved in the formation of proteins and enzymes.
Heparin is a type of peptide that has important medical uses. It is used as an anticoagulant to prevent blood clotting, and it can also be given as an injection to help dissolve existing blood clots.
Intravenous:
Intravenous (IV) market is a drug delivery system that delivers drugs into the blood vessels of the body. It is majorly used for the administration of medications and vaccines. The IV segment has been growing at a lucrative rate owing to increasing prevalence of chronic diseases, rising demand for home healthcare services, and technological advancements in this field.
Oral Route:
Oral route is the most common and easy way to administer drugs. It includes tablets, capsules, syrups, solutions and suspensions. The oral drug products can be easily administered by patients or consumers as they are in powdered or pellet form that can be mixed with beverages (such as water) or food items (like yogurt). Some oral dosage forms are even designed for children (like chewable tablets).
Application Insights:
The market is segmented by application into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy segment dominated the global peptide and heparin market in 2017 owing to factors such as increasing prevalence of chronic diseases such as cancer and diabetes which require regular medication. Moreover, growing awareness about the availability of advanced healthcare facilities coupled with rising incidences of trauma cases are expected to drive demand for peptide drugs in hospitals over the forecast period.
The retail pharmacy segment is anticipated to witness lucrative growth over the forecast period due to factors such as increasing consumer disposable income along with rising health consciousness among individuals aged 40 years or above group who constitute a major share of this sector. Rising adoption rate for these products among geriatric population suffering from low immunity due to conditions like Alzheimer¢â‚¬â„¢s disease or Parkinson¢â‚¬â„¢s disease will boost product demand in near future also.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of peptide developers and manufacturers, increasing incidence of chronic diseases, and high healthcare expenditure. Moreover, growing adoption by hospitals for various applications is expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising geriatric population prone to various disorders coupled with increasing awareness about peptide therapies among patients. Furthermore, economic development in countries such as India & China has led these nations being potential markets for Peptech’s products; therefore it can be presumed that Asia Pacific will emerge as one of the major regions during this time frame.
Growth Factors:
- Increasing demand for peptide and heparin products in the pharmaceutical and biotechnology industries for research and development purposes.
- Growing number of clinical studies that are being conducted on peptides and heparins as potential therapeutic agents.
- Rising incidence of cardiovascular diseases, cancer, and other chronic diseases that are being treated with peptides and heparins.
- increasing use of peptide-based drugs in the treatment of various medical conditions such as diabetes, obesity, Alzheimer's disease, etcetera . 5) technological advancements in the production of recombinant peptides and biosimilars that is expected to drive down the costs of these products over time
Scope Of The Report
Report Attributes
Report Details
Report Title
Peptide and Heparin Market Research Report
By Type
Intravenous, Oral Route, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Eli Lilly, Novo Nordisk, Sanofi, Pfizer, Abbott Laboratories, Takeda, Teva, Leo Pharma, Aspen, Bachem, Hemmo Pharma, Sun Pharmaceutical, Wockhardt, AmbioPharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global Peptide and Heparin Market Report Segments:
The global Peptide and Heparin market is segmented on the basis of:
Types
Intravenous, Oral Route, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eli Lilly
- Novo Nordisk
- Sanofi
- Pfizer
- Abbott Laboratories
- Takeda
- Teva
- Leo Pharma
- Aspen
- Bachem
- Hemmo Pharma
- Sun Pharmaceutical
- Wockhardt
- AmbioPharm
Highlights of The Peptide and Heparin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intravenous
- Oral Route
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peptide and Heparin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peptide is a molecule made up of amino acids. Heparin is a type of blood thinner that helps prevent clots from forming in the blood.
Some of the major companies in the peptide and heparin market are Eli Lilly, Novo Nordisk, Sanofi, Pfizer, Abbott Laboratories, Takeda, Teva, Leo Pharma, Aspen, Bachem, Hemmo Pharma, Sun Pharmaceutical, Wockhardt, AmbioPharm.
The peptide and heparin market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peptide and Heparin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Peptide and Heparin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Peptide and Heparin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Peptide and Heparin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Peptide and Heparin Market Size & Forecast, 2020-2028
4.5.1 Peptide and Heparin Market Size and Y-o-Y Growth
4.5.2 Peptide and Heparin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Intravenous
5.2.2 Oral Route
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Peptide and Heparin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Peptide and Heparin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Intravenous
9.6.2 Oral Route
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Intravenous
10.6.2 Oral Route
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Intravenous
11.6.2 Oral Route
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Intravenous
12.6.2 Oral Route
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Intravenous
13.6.2 Oral Route
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Peptide and Heparin Market: Competitive Dashboard
14.2 Global Peptide and Heparin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eli Lilly
14.3.2 Novo Nordisk
14.3.3 Sanofi
14.3.4 Pfizer
14.3.5 Abbott Laboratories
14.3.6 Takeda
14.3.7 Teva
14.3.8 Leo Pharma
14.3.9 Aspen
14.3.10 Bachem
14.3.11 Hemmo Pharma
14.3.12 Sun Pharmaceutical
14.3.13 Wockhardt
14.3.14 AmbioPharm
